PNPLA3 and metabolic dysfunction-associated steatotic liver disease: To gain further insight into the metabolic changes associated with the PNPLA3 I148M variant in MASLD, we performed multi-center NMR-based proteometabolomic analysis in 353 patients with MASLD stratified by PNPLA3 status.